Richard Koenig Joins ClinStar as Vice President, Operations
Published: Dec 21, 2011
SAN FRANCISCO, Dec. 20, 2011 /PRNewswire/ -- ClinStar, LLC, an established CRO providing clinical research services in the emerging markets of Russia and Eastern Europe to the pharmaceutical and biotechnology industry, announced today that Richard Koenig has joined the organization as Vice President, Operations.
Richard is a seasoned professional with over a decade of experience in the clinical research industry. His experience spans clinical operations, data management, operations management and IT. He has participated in the development, testing and maintenance of Enterprise Resource Planning and Clinical Trial Management systems. Most recently, Richard was an Executive Director with INC Research, where he was responsible for the relationship management of key sponsors, leading business development activities and direct oversight of study teams for CNS studies. Prior to joining the CRO industry in 1999, Richard spent 15 years working for the Federal Government in Northern Virginia in IT project management. Richard has a Masters in Health Care/Public Administration from Long Island University and was selected for a Presidential Management Internship upon graduation. Richard is based in ClinStar's offices in Durham, North Carolina.
In his new role with ClinStar, Richard will be responsible for project resourcing, project financial management and the development/maintenance of key project metrics. According to ClinStar President and CEO David Passov, "Richard's joining ClinStar marks an important milestone in the evolution of our company. His professional experience, educational background and strong leadership qualities make him an exemplary addition to our senior management team."
ClinStar announced last summer that it had opened a new office in Durham, NC to accommodate the organization's plans for future growth.
About ClinStar, LLC
ClinStar is one of the most prominent CROs in the emerging markets of Eastern Europe and the Baltics with more than 10 years of expertise in Phase I-IV clinical studies in multiple therapeutic areas. Headquartered in San Francisco, California, ClinStar manages studies from its offices in Russia, Ukraine and Belarus, with total staff of over 260 people. Its portfolio contains over 130 clinical trials conducted for US and European pharmaceutical and biotechnology companies. More information is available at www.clinstar.com.
SOURCE ClinStar, LLC